R3 Bio has a bold idea for replacing lab animals: genetically-engineered whole organ systems that lack a brain. The long-term ...
The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t ...
March 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday issued a draft guidance to help companies reduce ...
The FDA is eliminating “unnecessary testing” on animals, according to Commissioner Marty Makary. He joined “Katie Pavlich ...
On March 18, 2026, the Food and Drug Administration (FDA) issued draft guidance entitled “General Considerations for the Use of New ...
The Trump administration is redoubling its efforts to phase out animal testing in drug development and seeking to develop new ...
The guidance clarifies what sponsors should consider when putting together an application for the validation of a NAM ...
Health authorities in the U.S. are continuing their move away from animal testing in drug development, with the FDA signaling ...
In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from ...
The FDA’s recent announcement to reduce, and in some cases replace, animal testing for monoclonal antibodies and other ...
Animal studies often fail to predict human tissue responses to new drugs or newly developed therapies. Besides generating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results